ABOUT US公司简介

Hainan Periwinkle Pharmaceutical Co.,Ltd was established in 2005 and became a wholly-owned subsidiary of Guangzhou Person Pharmaceutical Co.,Ltd in 2015. Our company's API vincristine sulfate (approval number: GuoyaoZhunzi H20084628; record number: 20180000734) production line obtained the "GMP" certificate of CFDA on January 9, 2017. This is also the only production line of vincristine sulfate API in China that has passed the certification of GMP (2010 revised edition) and supply of domestic and foreign pharmaceuticals.

Vincristine sulfate is the active pharmaceutical ingredient for the production of vincristine sulfate for injection. It is clinically applied to various types of tumors, especially childhood acute leukemia, and has a significant effect on acute lymphoblastic leukemia.

The quality of our company's API vincristine sulfate reached the requirements of "Chinese Pharmacopoeia" (2015 edition) and USP35 edition, and was widely praised by domestic manufacturers of anti-tumor drugs. Our company has mature R&D technicians and production technicians of periwinkle products.

We insist on the unremitting pursuit of quality and safety, and strive to benefit the leukemia patients with high-quality products, and fulfill our mission of "transmitting healthy positive energy" with practical actions.

PRODUCTS产品中心
  • Vincristine sulfate
    CAS:2068-78-2
    Purity:≥96.0%
    Related substance:<3.5%
    Period of validity:2years
  • Vinblastine sulfate
    CAS:143-67-9
    Purity:≥96.0%
    Related substance:<3.0%
    Period of validity:2years
  • Vinorelbine tartrate
    CAS:125317-39-7
    Purity:≥98.0%
    Related substance:<1.0%
    Period of validity:2years
EQUIPMENT AND CERTIFICATES设备与证书
Contact us
  • Address: Gongye Rd , Wuzhishan City , Hainan Province
  • Postcode: 572200
  • Tel: 86-0898-86626689
Copyright Hainan Periwinkle Pharmaceutical Co.,Ltd All Rights Reserved  Qiong ICP No. 18003278 Design by:VIINOO